
Please try another search
Taiwan Liposome Company (NASDAQ:TLC), Ltd. Unsponsored ADR TLC shares soared 30.3% in the last trading session to close at $6.37. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 14.7% loss over the past four weeks.
The company's share price was driven by the approval for its Amphotericin B Liposome injection In India for treating mucormycosis or black fungus. The fungal infection is occuring as a post-COVID complication in 30% of COVID patients who are diabetic or otherwise immunocompromised, indicating a strong potential for Taiwan Liposome's injection in the country.
Price and Consensus
This company is expected to post quarterly loss of $0.25 per share in its upcoming report, which represents a year-over-year change of -13.6%. Revenues are expected to be $0.6 million, up 50% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Taiwan Liposome Company, Ltd. Unsponsored ADR, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on TLC going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank 2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Two weeks ago, see here, we found for the S&P 500, using the Elliott Wave Principle (EWP), “Our preferred scenario is for [a] rally to around $4490+/-10, which it achieved today,...
The second-quarter earnings period featured an impressive EPS beat rate, but guidance was less optimistic We found that dividend change announcement trends are also...
While the Russell 2000 has recovered from breaks of its 200-week MA before, every such test (and break) of the moving average increases the chance of a flip from a level of support...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.